These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22648001)

  • 61. Evaluation of a new automated chemiluminescence immunoassay for FGF23.
    Shimizu Y; Fukumoto S; Fujita T
    J Bone Miner Metab; 2012 Mar; 30(2):217-21. PubMed ID: 21898178
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure.
    Pramong N; Gojaseni P; Suttipongkeat S; Kiattisunthorn K; Chittinandana A
    Nephrology (Carlton); 2021 Feb; 26(2):126-133. PubMed ID: 32902010
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changes in plasma FGF23 in growth hormone deficient children during rhGH therapy.
    Gardner J; Ashraf A; You Z; McCormick K
    J Pediatr Endocrinol Metab; 2011; 24(9-10):645-50. PubMed ID: 22145450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial.
    Whyte MP; Carpenter TO; Gottesman GS; Mao M; Skrinar A; San Martin J; Imel EA
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):189-199. PubMed ID: 30638856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
    Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
    J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
    Gkentzi D; Efthymiadou A; Kritikou D; Chrysis D
    Bone; 2014 Sep; 66():8-14. PubMed ID: 24880094
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children.
    Holmlund-Suila E; Enlund-Cerullo M; Valkama S; Hauta-Alus H; Rosendahl J; Helve O; Hytinantti T; Viljakainen H; Andersson S; Mäkitie O
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4526-4533. PubMed ID: 29029193
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C.
    Young J; Mucsi I; Rollet-Kurhajec KC; Klein MB;
    HIV Med; 2016 May; 17(5):373-9. PubMed ID: 26307135
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
    Michigami T
    Clin Calcium; 2013 Oct; 23(10):1429-35. PubMed ID: 24076640
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structural and biochemical properties of fibroblast growth factor 23.
    Yamashita T
    Ther Apher Dial; 2005 Aug; 9(4):313-8. PubMed ID: 16076373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients.
    Chen Z; Chen X; Xie J; Ma X; Zhong F; Hou L; Ling H; Li X; Ren H; Chen N
    Ren Fail; 2013; 35(5):660-6. PubMed ID: 23581403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FGF23 is processed by proprotein convertases but not by PHEX.
    Benet-Pagès A; Lorenz-Depiereux B; Zischka H; White KE; Econs MJ; Strom TM
    Bone; 2004 Aug; 35(2):455-62. PubMed ID: 15268897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency.
    Bai XY; Miao D; Goltzman D; Karaplis AC
    J Biol Chem; 2003 Mar; 278(11):9843-9. PubMed ID: 12519781
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.
    Ichikawa S; Imel EA; Sorenson AH; Severe R; Knudson P; Harris GJ; Shaker JL; Econs MJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4472-5. PubMed ID: 16940445
    [TBL] [Abstract][Full Text] [Related]  

  • 78. FGF23 and Cause-Specific Mortality in Community-Living Individuals-The Health, Aging, and Body Composition Study.
    Sharma S; Katz R; Dubin RF; Drew DA; Gutierrez OM; Shlipak MG; Sarnak MJ; Ix JH
    J Am Geriatr Soc; 2021 Mar; 69(3):711-717. PubMed ID: 33170519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.